Profiel
Phillip Altman is the founder of Pharmaco Pty Ltd., ARCS Australia Ltd.
He worked as a Non-Executive Director at Viralytics Pty Ltd.
from 2009 to 2014.
Altman received his undergraduate, graduate, and doctorate degrees from The University of Sydney.
Actieve functies van Phillip Altman
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCS Australia Ltd. | Oprichter | 10-12-2010 |
Eerdere bekende functies van Phillip Altman
| Bedrijven | Functie | Einde |
|---|---|---|
| VIRALYTICS LTD. | Directeur/Bestuurslid | 01-09-2014 |
| Pharmaco Pty Ltd. | Oprichter | - |
Opleiding van Phillip Altman
| The University of Sydney | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
| Pharmaco Pty Ltd. | |
| ARCS Australia Ltd. |
